Skip to content

Efficacy of Combined Endoscopic Third Ventriculostomy and Choroid Plexus Cauterization in Treatment of Hydrocephalus

Efficacy of Combined Endoscopic Third Ventriculostomy and Choroid Plexus Cauterization as Primary Treatment for Paediatric Hydrocephalus

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07735936
Enrollment
90
Registered
2026-07-30
Start date
2026-07-01
Completion date
2029-08-01
Last updated
2026-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatric Hydrocephalus

Keywords

ETV, CPC, hydrocephalus

Brief summary

Hydrocephalus remains one of the most common conditions encountered in neurosurgery, traditionally managed by ventriculoperitoneal (VP) shunting. Despite its effectiveness, shunt dependency is associated with certain complications including infection, obstruction, and repeated revisions, leading to increased morbidity and healthcare burden. Over the last 70 years, cerebrospinal fluid (CSF) shunting and more recently endoscopic third ventriculostomy (ETV) have been the mainstays of hydrocephalus treatment. In recent years, choroid plexus cauterization (CPC) has re-emerged as an additional treatment strategy. In combination with ETV, CPC increases the chances of successfully treating some cases with hydrocephalus, than ETV alone. Endoscopic Third Ventriculostomy (ETV) has emerged as an alternative physiological treatment by creating a bypass for cerebrospinal fluid (CSF) flow. However, its success is limited in infants and in other varieties of hydrocephalus. The addition of Choroid Plexus Cauterization (CPC), which reduces CSF production, has been shown to improve outcomes when combined with ETV, particularly in younger patients. The idea is based on the principle that ablation of the predominant source of CSF secretion within the brain, choroid plexus (CP), reduces CSF production. In addition, CPC may reduce CSF pulsatility, an effect which may be potentiated when combined with ETV, which might reduce intraventricular pulsations by serving as a pulsation absorber. These effects, in combination, may tip the balance in favour of CSF absorption and negate the need for shunting in a proportion of patients. The combined ETV-CPC approach, popularized by Benjamin Warf, has demonstrated promising results in reducing shunt dependence, especially in resource-limited settings. However, variability in success rates persists due to differences in patient selection, etiology, and surgical expertise. This study aims at evaluation of the efficacy of combined ETV-CPC as a primary treatment modality for hydrocephalus and to identify predictors of surgical success and failure, thereby optimizing patient selection and improving outcomes.

Interventions

PROCEDURECombined endoscopic third ventriculostomy & coroid plexus cauterization

Using ETV \& CPC in paediatric hydrocephalus will reduce Complications as CSF leak and Infection, Hospital stay, Evaluate time to failure, Compare outcomes across different hydrocephalus aetiologies and Medical care cost.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children below 18 years * Radiologically diagnosed obstructive hydrocephalus * Late onset aqueductal stenosis cases

Exclusion criteria

* Communicating hydrocephalus. * Acute interventricular haemorrhage cases * Active infection cases * Multilocular hydrocephalus cases * Previous CSF diversion cases

Design outcomes

Primary

MeasureTime frameDescription
2. shunt-free survival2 years minimumlyThe period that patients underwent ETV \& CPC stays without need for shunt

Secondary

MeasureTime frame
Change in health care burden of paediatric hydrocephalus2 years minimumly
Change in rate of hospital admissions2 years minimumly

Countries

Egypt

Contacts

CONTACTIbraheem Ahmed Yosuf, Master degree
Ebrahim.ahmed@aun.edu.eg+20 01118440865

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 31, 2026